Coronaviruses
NFID Calls for Evidence-Based Guidance as Many People Skip Life-Saving Respiratory Vaccines
Survey reveals misconceptions about vaccines and declining vaccination rates
2025 National Survey on Respiratory Diseases
The 2025 national survey examines attitudes and behaviors regarding flu, RSV, COVID-19, and pneumococcal disease.
What You Need To Know This Respiratory Season
From antivirals to immunization, here’s what you need to know to help protect yourself and others from flu, COVID-19, RSV, and pneumococcal disease.
Staying on Track: Evidence-Based Vaccine Recommendations
Looking for trusted vaccine guidance? Read on for evidence-based immunization recommendations from professional medical groups and trusted NFID partners …
Medical Experts Urge Pregnant Women and Families to Talk with a Trusted Healthcare Professional about Respiratory Disease Prevention
Amid evolving and sometimes conflicting vaccine guidance, NFID kicks off its Respiratory Season News Briefing Series to help families facing tough decisions about their health
10/1/25 News Briefing: Respiratory Disease in Children and Pregnant Women
NFID will host the first in a series of 2025-2026 Respiratory Season News Briefings
From Shark Dreams to Global Health with Craig Spencer, MD, MPH
S3, E11: Craig Spencer, MD, MPH, emergency physician and global health expert, talks about what it takes to lead in times of crisis. From treating Ebola patients in Guinea to navigating COVID-19 in New York—and why the lessons of past pandemics must not be forgotten …
Infectious Diseases in the News
Read recent news of interest from the world of infectious diseases including insights and updates on COVID-19, handwashing, hepatitis, malaria, measles, and respiratory syncytial virus (RSV) …
Vaccines and Heart Health: A Vital Connection
Heart disease can increase the risk of serious or fatal complications from respiratory diseases including COVID-19, flu, and RSV
Harnessing the Power of Local Data
NFID dashboard aims to empower stakeholders with hyperlocal data to increase US adult respiratory vaccine uptake